TITLE

Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: how valid is the GABAergic hypothesis?

AUTHOR(S)
Bandini, F.; Castello, E.; Mazzella, L.; Mancardi, G. L.; Solaro, C.
PUB. DATE
July 2001
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Jul2001, p107
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66338054

 

Related Articles

  • The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study. Shery, T.; Proudlock, F. A.; Sarvananthan, N.; Mclean, R. J.; Gottlob, Irene // British Journal of Ophthalmology;Jul2006, Vol. 90 Issue 7, p839 

    Background: Pharmacological treatment has been successful in some farms of acquired neurological nystagmus. However, drugs are not known to be effective in idiopathic infantile nystogmus or nystagmus associated with ocular diseases. Methods: The authors retrospectively analysed Snellen visual...

  • Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin. Starck, Michaela; Albrecht, Holger; Pöllmann, Walter; Dieterich, Marianne; Straube, Andreas // Journal of Neurology;Mar2010, Vol. 257 Issue 3, p322 

    A prospective examiner-blind, cross-over study was conducted to compare the efficacy of memantine (40 or 60 mg/day) and gabapentin (1,200 mg/day) as therapy for acquired fixational pendular nystagmus (APN) in 11 patients with multiple sclerosis. APN was documented in 20 eyes by...

  • The pharmacological treatment of acquired nystagmus. Mehta, Arpan R.; Kennard, Christopher // Practical Neurology (BMJ Publishing Group);Jun2012, Vol. 12 Issue 3, p147 

    We review the latest literature on the neuropharmacological treatments for acquired nystagmus. Nystagmus may have a significantly impact on health, yet there is little scientific evidence on which to make firm recommendations for treatment. Acquired pendular nystagmus may respond to gabapentin...

  • Multiple Sclerosis and Nystagmus. Lee, Andrew G. // American Orthoptic Journal;2005, Vol. 55, p24 

    Purpose: To describe the main forms of nystagmus in multiple sclerosis (MS) and their potential treatments. Methods. A literature review on nystagmus and multiple sclerosis was performed using Medline and limited to English language publications from 1996-2004. Results: Internuclear...

  • Medications Acting on the GABA System in the Treatment of Alcoholic Patients. Caputo, Fabio; Bernardi, Mauro // Current Pharmaceutical Design;6/30/2010, Vol. 16 Issue 19, p2118 

    Gamma aminobutyric acid (GABA) represents the major inhibitory neurotransmitter of the central nervous system. Ethanol as well as benzodiazepines (BDZs) and some anticonvulsant drugs directly affect GABAA receptors inducing similar anxiolytic, sedative-hypnotic, and anticonvulsant effects. Since...

  • Perseverance in Philadelphia. Frames, Robin // Inside MS;Fall94, Vol. 12 Issue 3, p4 

    Relates the therapeutic interventions employed by Dorothea Williams to cope with multiple sclerosis (MS) related eye problems. Medical treatment of diplopia; Effects of nystagmus; Use of intravenous steroid for optic neuritis; Management of MS eye problems.

  • Living with a genetic disorder. Baum, Mandy // GP: General Practitioner;10/28/2002, p80 

    Discusses how the author physician's son being diagnosed with tuberous sclerosis changed her family's life. Symptoms of the disease noticed by the physician in her son; Medical consultations followed by the author for the treatment of her son; Use of anti-convulsant drug vigabatrin in the...

  • Symptomatic management.  // Multiple Sclerosis (13524585);Sep2004 Supplement 2, Vol. 10, p147 

    This article presents summary of articles, related to the symptomatic management of multiple sclerosis (MS). Acquired nystagmus causes significant symptoms of visual reduction with oscillopsia. The management includes medical and surgical interventions but evidence for both options is sparse....

  • Long-term vigabatrin use may damage inner retina. Charters, Lynda; Coupland, Stuart // Ophthalmology Times;04/15/2001, Vol. 26 Issue 8, p42 

    Focuses on a study on long-term use of vigabatrin, an anticonvulsant drug. Information on vigabatrin; Finding on a percentage of patients who are receiving long-term treatment with vigabatrin; Implication of the results in the vigabatrin multiple therapy group.

  • Uhthoff's sign.  // Taber's Cyclopedic Medical Dictionary;2005, p2259 

    A definition of the term "Uhthoff's sign" is presented. It refers to nystagmus that occurs in multiple sclerosis.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics